Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Immunotech Laboratories Inc    IMMB

Delayed Quote. Delayed  - 08/18 09:23:00 pm
0.0001 USD   +9 900.00%
01/25 IMMUNOTECH LABO : Announces Successful Completion of Phase III Testi..
2009 IMMUNOTECH LABO : Immunotech Completes Merger Acquisition
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
06/06/2017 08/07/2017 08/18/2017 08/21/2017 08/18/2017 Date
0(c) 1.0E-6(c) 0.0001(c) 0(c) 0.0001 Last
10 10 739 727 100 000 15 100 000 Volume
-100.00% +9900.00% -100.00% +9 900.00% Change
More quotes
Company
Immunotech Laboratories, Inc. is a drug development company.It engages in the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.The company was founded on April 11, 2000 and is headquartered in Glendale, CA. 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on IMMUNOTECH LABORATORIES IN
01/25 IMMUNOTECH LABORATORIES : Announces Successful Completion of Phase III Testing o..
2009 IMMUNOTECH LABORAT : Immunotech Completes Merger Acquisition
More news
Sector news : Bio Therapeutic Drugs
10/05DJAppeals Court Rules Against Amgen in Patent Case -- Update
10/05DJAppeals Court Rules Against Amgen in Patent Case
09/29 Merck to stop development of hepatitis C treatments
09/20DJSANOFI : Alnylam Report Positive Patisiran Phase III Trial, First-Ever for RNAi ..
09/15 Drug industry on tenterhooks as Maryland price-gouging law nears
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
2016 HERBALIFE : Never Again
Chart IMMUNOTECH LABORATORIES IN
Duration : Period :
Immunotech Laboratories In Technical Analysis Chart | IMMB | US45254F2039 | 4-Traders
Managers
NameTitle
Harry H. Zhabilov Chairman, President & Chief Science Officer
Valentin Ivanov Dimitrov Director
Billy Ray Head-Business & Development
Adam Samuel Tracy Legal Counsel
Sector and Competitors
1st jan.Capitalization (M$)
IMMUNOTECH LABORATORIES INC-88.89%0
GILEAD SCIENCES13.35%106 002
REGENERON PHARMACEUTICALS20.67%47 464
VERTEX PHARMACEUTICALS107.56%38 551
ACTELION23.24%29 919
GENMAB22.08%13 910